Syndax Pharmaceuticals, Inc.
SNDX
$10.99
$0.292.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.51% | 0.92% | 8.71% | 6.46% | 1.13% |
| Total Receivables | 183.18% | 1,030.48% | 11.80% | 1,937.83% | 266.12% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.52% | 164.35% | 30.77% | 26.84% | 188.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 548.19% | 871.43% | -21.30% | -77.78% | -51.18% |
| Total Current Assets | 20.90% | 3.82% | 8.88% | 9.04% | 2.81% |
|
|
|||||
| Total Current Assets | 20.90% | 3.82% | 8.88% | 9.04% | 2.81% |
| Net Property, Plant & Equipment | 44.31% | 35.25% | -56.58% | -49.42% | 31.92% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -53.33% | -68.09% | -73.01% | -53.14% | -42.45% |
| Total Assets | 17.99% | 18.26% | 6.66% | 10.57% | 18.09% |
|
|
|||||
| Total Accounts Payable | 14.05% | 16.72% | -19.03% | 5.37% | 9.33% |
| Total Accrued Expenses | 77.01% | 53.14% | 52.83% | 54.63% | 122.86% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,278.84% | 1,103.06% | -15.31% | 2.58% | 129.63% |
| Total Finance Division Other Current Liabilities | 48.01% | 142.02% | 644.01% | 223.47% | 1,126.60% |
| Total Other Current Liabilities | 48.01% | 142.02% | 644.01% | 223.47% | 1,126.60% |
| Total Current Liabilities | 86.11% | 78.24% | 51.57% | 40.78% | 114.18% |
|
|
|||||
| Total Current Liabilities | 86.11% | 78.24% | 51.57% | 40.78% | 114.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 335.03% | 168.37% | -99.77% | -87.89% | -44.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 732.34% | 644.14% | 48.31% | 36.14% | 110.27% |
|
|
|||||
| Common Stock & APIC | 3.62% | 3.62% | 25.51% | 25.32% | 25.42% |
| Retained Earnings | -33.98% | -35.32% | -35.79% | -33.91% | -32.78% |
| Treasury Stock & Other | 169.71% | -25.23% | 181.54% | -42.33% | -125.00% |
| Total Common Equity | -56.28% | -48.01% | 2.02% | 8.57% | 12.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -56.28% | -48.01% | 2.02% | 8.57% | 12.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -56.28% | -48.01% | 2.02% | 8.57% | 12.95% |
|
|
|||||